Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β

Subhas Chakrabarty, Yih Jan, Michael G. Brattain, Andrew Tobon, James Varani

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

We have recently characterized the growth-inhibitory and cellular responses [carcinoembryonic antigen (CEA) secretion, protein secretion, protein expression, fibronectin and laminin synthesis) of the human colon carcinoma MOSER cell line to transforming growth factor-β (TGF-β) (Cancer Res., 47: 2950, 1987; 48: 4059, 1988). We have also recently isolated a subline (MOSER R2) from the parental MOSER cells which, unlike the parental line, is relatively resistant to the growth-inhibitory effect of TGF-β (Biochem. Biophys. Res. Commun., 150:711,1988). We now report on the characterization of the cellular responses of this resistant MOSER R2 subline to TGF-β and compare its responses to that of the highly growth-inhibition-sensitive MOSER cell line. In view of the reported relationship between CEA expression and differentiation in colon cancer and the ability of colon-derived substrata material to modulate the phenotypic properties of colon cancer cells, additional characterization and direct comparison of the effects of TGF-β on the two cell lines were also performed with respect to (a) cellular expression of CEA and CEA cross-reactive glycoproteins; and (b) colon-derived substrata material. Unlike the growth-inhibition-sensitive MOSER cells, TGF-β had no effects on fibronectin/laminin synthesis nor on the cellular morphology of the resistant MOSER R2 cells. TGF-β was also unable to modulate protein secretion and deposition of substrata material by these cells. However, several other responses of the resistant cells to TGF-β were found to be similar to that of the sensitive MOSER cells. These responses include: (a) a prolonged and stable secretion of CEA; (b) a prolonged and stable induction of elevated cellular expression of CEA and CEA cross-reactive glycoproteins; and (c) enhancement of the expression of three cellular proteins with molecular weights corresponding to 52,000,48,000, and 42,000. We further report that the differences observed in the responses to TGF-β in the two cell lines were not due to differences in TGF-β binding or other receptor parameters such as the expression of distinct TGF-β receptor subspecies.

Original languageEnglish (US)
Pages (from-to)2112-2117
Number of pages6
JournalCancer Research
Volume49
Issue number8
StatePublished - Apr 1989

Fingerprint

Transforming Growth Factors
Colon
Carcinoembryonic Antigen
Carcinoma
Colonic Neoplasms
Cell Line
Laminin
Growth
Fibronectins
Glycoproteins
Proteins
Growth Factor Receptors
Molecular Weight

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Chakrabarty, S., Jan, Y., Brattain, M. G., Tobon, A., & Varani, J. (1989). Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β. Cancer Research, 49(8), 2112-2117.

Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β. / Chakrabarty, Subhas; Jan, Yih; Brattain, Michael G.; Tobon, Andrew; Varani, James.

In: Cancer Research, Vol. 49, No. 8, 04.1989, p. 2112-2117.

Research output: Contribution to journalArticle

Chakrabarty, S, Jan, Y, Brattain, MG, Tobon, A & Varani, J 1989, 'Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β', Cancer Research, vol. 49, no. 8, pp. 2112-2117.
Chakrabarty S, Jan Y, Brattain MG, Tobon A, Varani J. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β. Cancer Research. 1989 Apr;49(8):2112-2117.
Chakrabarty, Subhas ; Jan, Yih ; Brattain, Michael G. ; Tobon, Andrew ; Varani, James. / Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β. In: Cancer Research. 1989 ; Vol. 49, No. 8. pp. 2112-2117.
@article{c374fff5375b4eed9ec7e0e287383360,
title = "Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β",
abstract = "We have recently characterized the growth-inhibitory and cellular responses [carcinoembryonic antigen (CEA) secretion, protein secretion, protein expression, fibronectin and laminin synthesis) of the human colon carcinoma MOSER cell line to transforming growth factor-β (TGF-β) (Cancer Res., 47: 2950, 1987; 48: 4059, 1988). We have also recently isolated a subline (MOSER R2) from the parental MOSER cells which, unlike the parental line, is relatively resistant to the growth-inhibitory effect of TGF-β (Biochem. Biophys. Res. Commun., 150:711,1988). We now report on the characterization of the cellular responses of this resistant MOSER R2 subline to TGF-β and compare its responses to that of the highly growth-inhibition-sensitive MOSER cell line. In view of the reported relationship between CEA expression and differentiation in colon cancer and the ability of colon-derived substrata material to modulate the phenotypic properties of colon cancer cells, additional characterization and direct comparison of the effects of TGF-β on the two cell lines were also performed with respect to (a) cellular expression of CEA and CEA cross-reactive glycoproteins; and (b) colon-derived substrata material. Unlike the growth-inhibition-sensitive MOSER cells, TGF-β had no effects on fibronectin/laminin synthesis nor on the cellular morphology of the resistant MOSER R2 cells. TGF-β was also unable to modulate protein secretion and deposition of substrata material by these cells. However, several other responses of the resistant cells to TGF-β were found to be similar to that of the sensitive MOSER cells. These responses include: (a) a prolonged and stable secretion of CEA; (b) a prolonged and stable induction of elevated cellular expression of CEA and CEA cross-reactive glycoproteins; and (c) enhancement of the expression of three cellular proteins with molecular weights corresponding to 52,000,48,000, and 42,000. We further report that the differences observed in the responses to TGF-β in the two cell lines were not due to differences in TGF-β binding or other receptor parameters such as the expression of distinct TGF-β receptor subspecies.",
author = "Subhas Chakrabarty and Yih Jan and Brattain, {Michael G.} and Andrew Tobon and James Varani",
year = "1989",
month = "4",
language = "English (US)",
volume = "49",
pages = "2112--2117",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β

AU - Chakrabarty, Subhas

AU - Jan, Yih

AU - Brattain, Michael G.

AU - Tobon, Andrew

AU - Varani, James

PY - 1989/4

Y1 - 1989/4

N2 - We have recently characterized the growth-inhibitory and cellular responses [carcinoembryonic antigen (CEA) secretion, protein secretion, protein expression, fibronectin and laminin synthesis) of the human colon carcinoma MOSER cell line to transforming growth factor-β (TGF-β) (Cancer Res., 47: 2950, 1987; 48: 4059, 1988). We have also recently isolated a subline (MOSER R2) from the parental MOSER cells which, unlike the parental line, is relatively resistant to the growth-inhibitory effect of TGF-β (Biochem. Biophys. Res. Commun., 150:711,1988). We now report on the characterization of the cellular responses of this resistant MOSER R2 subline to TGF-β and compare its responses to that of the highly growth-inhibition-sensitive MOSER cell line. In view of the reported relationship between CEA expression and differentiation in colon cancer and the ability of colon-derived substrata material to modulate the phenotypic properties of colon cancer cells, additional characterization and direct comparison of the effects of TGF-β on the two cell lines were also performed with respect to (a) cellular expression of CEA and CEA cross-reactive glycoproteins; and (b) colon-derived substrata material. Unlike the growth-inhibition-sensitive MOSER cells, TGF-β had no effects on fibronectin/laminin synthesis nor on the cellular morphology of the resistant MOSER R2 cells. TGF-β was also unable to modulate protein secretion and deposition of substrata material by these cells. However, several other responses of the resistant cells to TGF-β were found to be similar to that of the sensitive MOSER cells. These responses include: (a) a prolonged and stable secretion of CEA; (b) a prolonged and stable induction of elevated cellular expression of CEA and CEA cross-reactive glycoproteins; and (c) enhancement of the expression of three cellular proteins with molecular weights corresponding to 52,000,48,000, and 42,000. We further report that the differences observed in the responses to TGF-β in the two cell lines were not due to differences in TGF-β binding or other receptor parameters such as the expression of distinct TGF-β receptor subspecies.

AB - We have recently characterized the growth-inhibitory and cellular responses [carcinoembryonic antigen (CEA) secretion, protein secretion, protein expression, fibronectin and laminin synthesis) of the human colon carcinoma MOSER cell line to transforming growth factor-β (TGF-β) (Cancer Res., 47: 2950, 1987; 48: 4059, 1988). We have also recently isolated a subline (MOSER R2) from the parental MOSER cells which, unlike the parental line, is relatively resistant to the growth-inhibitory effect of TGF-β (Biochem. Biophys. Res. Commun., 150:711,1988). We now report on the characterization of the cellular responses of this resistant MOSER R2 subline to TGF-β and compare its responses to that of the highly growth-inhibition-sensitive MOSER cell line. In view of the reported relationship between CEA expression and differentiation in colon cancer and the ability of colon-derived substrata material to modulate the phenotypic properties of colon cancer cells, additional characterization and direct comparison of the effects of TGF-β on the two cell lines were also performed with respect to (a) cellular expression of CEA and CEA cross-reactive glycoproteins; and (b) colon-derived substrata material. Unlike the growth-inhibition-sensitive MOSER cells, TGF-β had no effects on fibronectin/laminin synthesis nor on the cellular morphology of the resistant MOSER R2 cells. TGF-β was also unable to modulate protein secretion and deposition of substrata material by these cells. However, several other responses of the resistant cells to TGF-β were found to be similar to that of the sensitive MOSER cells. These responses include: (a) a prolonged and stable secretion of CEA; (b) a prolonged and stable induction of elevated cellular expression of CEA and CEA cross-reactive glycoproteins; and (c) enhancement of the expression of three cellular proteins with molecular weights corresponding to 52,000,48,000, and 42,000. We further report that the differences observed in the responses to TGF-β in the two cell lines were not due to differences in TGF-β binding or other receptor parameters such as the expression of distinct TGF-β receptor subspecies.

UR - http://www.scopus.com/inward/record.url?scp=0024535866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024535866&partnerID=8YFLogxK

M3 - Article

C2 - 2539253

AN - SCOPUS:0024535866

VL - 49

SP - 2112

EP - 2117

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 8

ER -